Invention Grant
- Patent Title: Polymorphs of ARRY-380, a selective HER2 inhibitor and pharmaceutical compositions containing them
-
Application No.: US16942094Application Date: 2020-07-29
-
Publication No.: US11571424B2Publication Date: 2023-02-07
- Inventor: Donald T. Corson , Christopher M. Lindemann , Daniel J. Watson
- Applicant: Array BioPharma Inc.
- Applicant Address: US CO Boulder
- Assignee: Array BioPharma Inc.
- Current Assignee: Array BioPharma Inc.
- Current Assignee Address: US CO Boulder
- Agency: Viksnins Harris Padys Malen LLP
- Main IPC: A61K31/517
- IPC: A61K31/517 ; A61K31/437 ; A61P35/00 ; C07D471/04 ; A61K45/06
Abstract:
Polymorphs of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine are provided herein. Processes for preparing the polymorphs and pharmaceutical composition comprising the polymorphs are also disclosed.
Public/Granted literature
- US20210077493A1 POLYMORPHS OF ARRY-380, A SELECTIVE HER2 INHIBITOR AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM Public/Granted day:2021-03-18
Information query
IPC分类:
